SRNE
Sorrento Therapeutics Inc
Price:  
0.31 
USD
Volume:  
176,993,280.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SRNE WACC - Weighted Average Cost of Capital

The WACC of Sorrento Therapeutics Inc (SRNE) is 7.6%.

The Cost of Equity of Sorrento Therapeutics Inc (SRNE) is 21.65%.
The Cost of Debt of Sorrento Therapeutics Inc (SRNE) is 5.50%.

Range Selected
Cost of equity 15.30% - 28.00% 21.65%
Tax rate 0.60% - 1.60% 1.10%
Cost of debt 4.00% - 7.00% 5.50%
WACC 5.5% - 9.7% 7.6%
WACC

SRNE WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 2.48 4.13
Additional risk adjustments 0.0% 0.5%
Cost of equity 15.30% 28.00%
Tax rate 0.60% 1.60%
Debt/Equity ratio 6.42 6.42
Cost of debt 4.00% 7.00%
After-tax WACC 5.5% 9.7%
Selected WACC 7.6%